TØNSBERG,Norway,Nov. 22,2024 -- poLight ASA (OSE: PLT) today announced that the company has received a purchase order worth approximately NOK 500,000 to supply its TWedge® wobulator technical samples to a top tier consumer OEM customer for an AR/MR application.
"Our customer interactions related to TWedge® wobulator technology provide key insights as we define this potential new product," said Dr. Øyvind Isaksen,CEO of poLight ASA. "TWedge® wobulator is based on the same tunable optics technology platform as our TLens® product used in numerous auto focus imaging systems. While there will be many steps between technical sample evaluation,productization,and potential mass production supply into customer devices,this milestone is an important step for our TWedge® wobulator technology and we are encouraged by the continued interests from many of our customers. In addition,this customer is also evaluating our TLens® product to differentiate their imaging device. We have no doubt that both TLens® and TWedge® wobulator technology can solve many AR/MR design challenges."
The delivery of the TWedge® technical samples is expected to be completed in Q1 2025.
CONTACT:
For further information,please contact:
Dr Øyvind Isaksen,CEO,poLight ASA: +4790 87 63 98
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/polight/r/polight-asa-receives-purchase-order-for-twedge--wobulator-technical-samples-from-a-top-tier-consumer,c4070063
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map